Xilio Therapeutics, Inc.: Form 8-K, filed Mar 12, 2026
Filed with the SEC on Mar 12, 2026 and accepted by EDGAR at Mar 12, 2026, 08:34 ET.
Items reported
- Item 3.03 Change to security holders’ rights
- Item 5.03 Amendment to articles or bylaws
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-103150. Last ingested by Listed: Nov 15, 2026, 04:19 ET. Listed shows no prices and gives no investment advice.